about
Reduction of conductance-based neuron modelsReview of 54 patients with complete DiGeorge anomaly enrolled in protocols for thymus transplantation: outcome of 44 consecutive transplantsPathway level analysis of gene expression using singular value decompositionIdentifying differential expression in multiple SAGE libraries: an overdispersed log-linear model approachCo-evolution of a broadly neutralizing HIV-1 antibody and founder virusBroadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutininPreconfiguration of the antigen-binding site during affinity maturation of a broadly neutralizing influenza virus antibody.Vaccine Induction of Antibodies against a Structurally Heterogeneous Site of Immune Pressure within HIV-1 Envelope Protein Variable Regions 1 and 2Morphologic analysis correlates with gene expression changes in cultured F344 rat mesothelial cellsH3N2 influenza infection elicits more cross-reactive and less clonally expanded anti-hemagglutinin antibodies than influenza vaccinationFirst qualification study of serum biomarkers as indicators of total body burden of osteoarthritisOpen Source Research — the Power of UsSelective and site-specific mobilization of dermal dendritic cells and Langerhans cells by Th1- and Th2-polarizing adjuvants.Spatial Mixture Modelling for Unobserved Point Processes: Examples in Immunofluorescence HistologyStatistical analysis of antigen receptor spectratype data.SpA: web-accessible spectratype analysis: data management, statistical analysis and visualization.Unselected mutations in the human immunodeficiency virus type 1 genome are mostly nonsynonymous and often deleteriousSoDA: implementation of a 3D alignment algorithm for inference of antigen receptor recombinations.Improving peptide-MHC class I binding prediction for unbalanced datasets.The dynamics of T-cell receptor repertoire diversity following thymus transplantation for DiGeorge anomalyChiropteran types I and II interferon genes inferred from genome sequencing traces by a statistical gene-family assembler.Invertebrate immune systems--not homogeneous, not simple, not well understood.Metastasizing patent claims on BRCA1Toxin-coupled MHC class I tetramers can specifically ablate autoreactive CD8+ T cells and delay diabetes in nonobese diabetic mice.Surface plasmon resonance measurements of plasma antibody avidity during primary and secondary responses to anthrax protective antigen.A two-tiered model for simulating the ecological and evolutionary dynamics of rapidly evolving viruses, with an application to influenza.Envelope deglycosylation enhances antigenicity of HIV-1 gp41 epitopes for both broad neutralizing antibodies and their unmutated ancestor antibodies.Isolation of a human anti-HIV gp41 membrane proximal region neutralizing antibody by antigen-specific single B cell sorting.Advantage of rare HLA supertype in HIV disease progression.B-cell-lineage immunogen design in vaccine development with HIV-1 as a case studyMixtures of Gaussian Wells: Theory, Computation, and ApplicationIdentification of autoantigens recognized by the 2F5 and 4E10 broadly neutralizing HIV-1 antibodiesStatistical inference of sequence-dependent mutation rates.Quantification of total T-cell receptor diversity by flow cytometry and spectratyping.The T helper type 2 response to cysteine proteases requires dendritic cell-basophil cooperation via ROS-mediated signaling.Analysis of a clonal lineage of HIV-1 envelope V2/V3 conformational epitope-specific broadly neutralizing antibodies and their inferred unmutated common ancestors.Initial antibodies binding to HIV-1 gp41 in acutely infected subjects are polyreactive and highly mutatedTwo distinct broadly neutralizing antibody specificities of different clonal lineages in a single HIV-1-infected donor: implications for vaccine design.Boosting of HIV envelope CD4 binding site antibodies with long variable heavy third complementarity determining region in the randomized double blind RV305 HIV-1 vaccine trial.Drug concentration heterogeneity facilitates the evolution of drug resistance.
P50
Q22337372-A0D2608D-D6BB-40CB-B052-F4922176C7F4Q24678401-DE048D6D-D582-438E-84C9-5727671B185BQ24814174-E78ED641-D005-4DF6-BC6D-5942081A6914Q24815096-2CCBE410-8E0C-4725-9970-39FEC433831DQ27644501-F71FD9FC-4CD9-48AD-B5F9-C161B537EE76Q27671619-1F484832-1B53-4107-AE21-41D142F3F900Q27675207-90314B83-28DF-4272-BB83-A7CA2B86E094Q27675879-F660D1DC-4C67-48D4-93CA-CEB53A880B37Q28572290-37C10494-4679-4A70-A484-F762648D0286Q28743596-24C7538E-EA87-49DE-AC53-91E715905247Q28748487-3D2A22DB-A891-4F6A-A627-7C9C2FA4DF95Q29307029-DDD37DFB-1A7E-4977-81AA-AFB6BE61FB42Q30495004-3852CB49-8D2A-4A4E-A847-A7965ADF4E5EQ30497163-AE5FA445-9DB5-4E69-8142-6DD92ACAAEC5Q30992040-A4C29130-B5BE-4ECE-8235-6B82BFD35F8BQ30997115-3C266AF9-2A92-4C4E-B8D0-91ED6E00EB81Q31047702-019D46ED-D0E2-4F13-BFE1-17E62DF7AC28Q33229588-AB9181CC-8393-4BD5-A918-06EA787ED81FQ33370669-455CAFD9-28E9-459E-9410-D3E93352C84DQ33466761-F2149D0E-36F1-4B75-9F8F-A5CF5A9A72A7Q33642157-2E6E7BE5-9E6C-4F7F-AE70-3B6866837593Q33664494-8ECBB541-6038-4E46-BF0A-DCE13C9D5586Q33802408-07421364-6E2E-4536-9780-B8FC4F3F8A67Q33844333-F310F4D0-F4F3-4281-9E32-1BEA1377DF7AQ33922778-B112B93A-352B-4EEE-92EC-9BE853220252Q33952210-EDF0AD3B-1C7A-4841-9F6A-39A6D6AB2484Q34016211-61E6587D-2ED9-4818-9FDF-B563B1BD0ED1Q34042758-C42DFC33-2027-4A6A-BD50-4721EAB38F73Q34207773-C345D838-A045-4D8C-9AD8-6A5C354122C0Q34273373-0A998B7E-2426-4051-99A5-A47EB3F34AD8Q34323976-EA8509E2-E5DB-46EB-9C8E-9ADB8AD57A1BQ34324992-D19F9084-9F66-47F3-98DA-234A68B2D43EQ34420737-3CB8F2A7-41AE-4B69-B6F3-6E6E0BE653D9Q34892584-EE5D3BFD-AC62-4CEE-A761-FB5D9DD30607Q35132544-6063AEA7-AC17-4433-BEAE-62DD31E01DB5Q35382871-BA171F1E-4749-427F-A070-FDCB7238409FQ35441583-0E6F443E-A21C-44CE-A29E-B3B6145507FEQ35868076-5E38C9B2-BE59-4FE2-B456-864C01B1C6FFQ36290038-BCC35BF3-05B9-4A9F-A1D4-3839F87F7176Q36312295-643C95B8-1813-4F25-9AAA-4CD932138A29
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Thomas B. Kepler
@ast
Thomas B. Kepler
@en
Thomas B. Kepler
@es
Thomas B. Kepler
@nl
Thomas B. Kepler
@sl
type
label
Thomas B. Kepler
@ast
Thomas B. Kepler
@en
Thomas B. Kepler
@es
Thomas B. Kepler
@nl
Thomas B. Kepler
@sl
altLabel
T.B. Kepler
@en
prefLabel
Thomas B. Kepler
@ast
Thomas B. Kepler
@en
Thomas B. Kepler
@es
Thomas B. Kepler
@nl
Thomas B. Kepler
@sl
P106
P1153
7004537298
P21
P31
P496
0000-0002-1383-6865